drugset / Trial / NCT06454708

Pharmacokinetics, Safety and Tolerability of Clascoterone Cream 1% in Healthy Chinese Adult Subjects

NCT06454708

Phase 1 Completed 12 enrolled Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The primary objective of this study is to determine the pharmacokinetics (PK) of Clascoterone Cream, 1% after single dose and repeat dose topical administrations in healthy Chinese adult subjects.

Timeline

Start
2024-08-01
Primary completion
2024-08-12
Completion
2024-08-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Clascoterone Small molecule 1 % Topical

Indications